141 related articles for article (PubMed ID: 19523464)
21. Myocardial injury in coronary artery bypass grafting: on-pump versus off-pump comparison by measuring high-sensitivity C-reactive protein, cardiac troponin I, heart-type fatty acid-binding protein, creatine kinase-MB, and myoglobin release.
Chowdhury UK; Malik V; Yadav R; Seth S; Ramakrishnan L; Kalaivani M; Reddy SM; Subramaniam GK; Govindappa R; Kakani M
J Thorac Cardiovasc Surg; 2008 May; 135(5):1110-9, 1119.e1-10. PubMed ID: 18455592
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic utility of new immunoassays for the cardiac markers cTnI, myoglobin and CK-MB mass.
Weber M; Rau M; Madlener K; Elsaesser A; Bankovic D; Mitrovic V; Hamm C
Clin Biochem; 2005 Nov; 38(11):1027-30. PubMed ID: 16125162
[TBL] [Abstract][Full Text] [Related]
23. Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarction.
Kavsak PA; MacRae AR; Newman AM; Lustig V; Palomaki GE; Ko DT; Tu JV; Jaffe AS
Clin Chim Acta; 2007 May; 380(1-2):213-6. PubMed ID: 17306781
[TBL] [Abstract][Full Text] [Related]
24. Prediction of Recurrent Events by D-Dimer and Inflammatory Markers in Patients with Normal Cardiac Troponin I (PREDICT) Study.
Menown IB; Mathew TP; Gracey HM; Nesbitt GS; Murray P; Young IS; Adgey AA;
Am Heart J; 2003 Jun; 145(6):986-92. PubMed ID: 12796753
[TBL] [Abstract][Full Text] [Related]
25. Influence of hemolysis on routine laboratory cardiac marker testing.
Daves M; Salvagno GL; Cemin R; Gelati M; Cervellin G; Guidi GC; Lippi G
Clin Lab; 2012; 58(3-4):333-6. PubMed ID: 22582509
[TBL] [Abstract][Full Text] [Related]
26. Emerging cardiac markers in coronary disease: role of brain natriuretic peptide and other biomarkers.
Palazzuoli A; Iovine F; Gallotta M; Nuti R
Minerva Cardioangiol; 2007 Aug; 55(4):491-6. PubMed ID: 17653025
[TBL] [Abstract][Full Text] [Related]
27. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission.
Weber M; Bazzino O; Navarro Estrada JL; Fuselli JJ; Botto F; Perez de Arenaza D; Möllmann H; Nef HN; Elsässer A; Hamm CW
J Am Coll Cardiol; 2008 Mar; 51(12):1188-95. PubMed ID: 18355657
[TBL] [Abstract][Full Text] [Related]
28. Biomarkers in acute cardiovascular disease.
Howie-Esquivel J; White M
J Cardiovasc Nurs; 2008; 23(2):124-31. PubMed ID: 18382255
[TBL] [Abstract][Full Text] [Related]
29. Cardiac markers in the assessment of acute coronary syndromes.
Christenson RH; Newby LK; Ohman EM
Md Med J; 1997; Suppl():18-24. PubMed ID: 9470339
[TBL] [Abstract][Full Text] [Related]
30. Multicentre analytical evaluation of a new point-of-care system for the determination of cardiac and thromboembolic markers.
Bertsch T; Chapelle JP; Dempfle CE; Giannitsis E; Schwabs M; Zerback R
Clin Lab; 2010; 56(1-2):37-49. PubMed ID: 20380358
[TBL] [Abstract][Full Text] [Related]
31. Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia.
Venge P; Johnston N; Lindahl B; James S
J Am Coll Cardiol; 2009 Sep; 54(13):1165-72. PubMed ID: 19761938
[TBL] [Abstract][Full Text] [Related]
32. Response to cardiac markers in human serum analyzed by guided-mode resonance biosensor.
Kim WJ; Kim BK; Kim A; Huh C; Ah CS; Kim KH; Hong J; Park SH; Song S; Song J; Sung GY
Anal Chem; 2010 Dec; 82(23):9686-93. PubMed ID: 21049960
[TBL] [Abstract][Full Text] [Related]
33. [Evaluation of the analytical performance characteristics of NT-proBNP immunoassay on dimension RxL-HM (Dade Behring)].
Benoit MO; Dautezac F; Taccoen M; Paul JL
Ann Biol Clin (Paris); 2005; 63(4):411-6. PubMed ID: 16061439
[TBL] [Abstract][Full Text] [Related]
34. [Serum sCD40L detection for risk evaluation of acute coronary syndromes].
Xu BL; Bei CH; Wang R; Lei XX
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1656-7. PubMed ID: 17121725
[TBL] [Abstract][Full Text] [Related]
35. Comparison of cardiac troponin I versus T and creatine kinase MB after coronary artery bypass grafting in patients with and without perioperative myocardial infarction.
Peivandi AA; Dahm M; Opfermann UT; Peetz D; Doerr F; Loos A; Oelert H
Herz; 2004 Nov; 29(7):658-64. PubMed ID: 15580320
[TBL] [Abstract][Full Text] [Related]
36. Improved early risk stratification and diagnosis of myocardial infarction, using a novel troponin I assay concept.
Ilva T; Eriksson S; Lund J; Porela P; Mustonen H; Pettersson K; Pulkki K; Voipio-Pulkki LM
Eur J Clin Invest; 2005 Feb; 35(2):112-6. PubMed ID: 15667582
[TBL] [Abstract][Full Text] [Related]
37. Development of an optimized multimarker strategy for early risk assessment of patients with acute coronary syndromes.
Möckel M; Danne O; Müller R; Vollert JO; Müller C; Lueders C; Störk T; Frei U; Koenig W; Dietz R; Jaffe AS
Clin Chim Acta; 2008 Jul; 393(2):103-9. PubMed ID: 18423399
[TBL] [Abstract][Full Text] [Related]
38. Elevated CK-MB mass and plasma brain-type natriuretic peptide concentrations following convulsive seizures in children and adolescents: possible evidence of subtle cardiac dysfunction.
Alehan F; Erol I; Cemil T; Bayraktar N; Ogüs E; Tokel K
Epilepsia; 2009 Apr; 50(4):755-60. PubMed ID: 19183225
[TBL] [Abstract][Full Text] [Related]
39. Seemingly healthy 71-year-old men with minor elevations of cardiac troponin I and at risk of premature death in CVD have elevated levels of NT-proBNP: report from the ULSAM study.
Venge P; Arnlöv J; Zethelius B
Scand J Clin Lab Invest; 2009; 69(3):418-24. PubMed ID: 19221927
[TBL] [Abstract][Full Text] [Related]
40. Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.
Figiel Ł; Kasprzak JD; Peruga J; Lipiec P; Drozdz J; Krzemińska-Pakuła M; Smigielski J
Kardiol Pol; 2008 Mar; 66(3):253-9, discussion 260-1. PubMed ID: 18393112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
